|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Dysmenorrhea | |||||
| 2 | More general conditions related to this trial | ||||
| Menstruation Disturbances | |||||
| Pain | |||||
| Pathologic Processes | |||||
| Pelvic Pain | |||||
| Signs and Symptoms | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Vitamin K | |||||
| 4 | More general drug interventions related to this trial | ||||
| Antifibrinolytic Agents | |||||
| Coagulants | |||||
| Fibrin Modulating Agents | |||||
| Growth Substances | |||||
| Hematologic Agents | |||||
| Hemostatics | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vitamins | |||||
| 5 | Sponsors listed in this trial | ||||
| National Center for Complementary and Alternative Medicine (NCCAM) | |||||